2022. Current Options for Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma. Journal of Kidney Cancer. 9, 3 (Sep. 2022), 29–40. DOI:https://doi.org/10.15586/jkcvhl.v9i3.243.